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Abstract 
Problem Statement: Cancer is a complex genetic disease. Evidence is emerging that particular microRNAs may play a role in 
human cancer pathogenesis; they exhibit important regulatory roles in development, cell proliferation, cell survival and apoptosis 
[1]. The effectiveness in treatment and curing cancer is directly dependent on the ability to detect cancers at their earlier stages. 
This study developed a neural network with back-propagation learning algorithm for the prediction of microRNAs responsible 
from cancer pathogenesis at earlier stages.  Purpose of the Study: The aim of this research was to develop a nonlinear empirical 
model to predict a score value for specific microRNAs responsible from cancer pathogenesis by using micro-array data.    
Methods: The Back-Propagation Multi Layer perceptron (BPMLP) for the prediction of score value. The supervised learning 
algoritm is used during the training and testing stages. The number of inputs is fixed at two and the number of output is one. The 
677 micro-array data were collected from a cancer microarray database and data-mining platform called Oncomine. Testing data 
are classified into randomly selected four groups of data.  Findings and Results:  In this work, a BPMLP, is used to establish the 
relationship between the microRNAs, p-value and score value. Accuracy rate was adjusted to 80 % and 90 %. The best 
performance was obtained with 20 neurons in the hidden layer and learning parameter as 0.00099.  Conclusions and 
Recommendations:  BPMLP is obtained by developing forward propagation phase and sensitivity network. It is shown that, the 
generalization capability can be significantly improved by optimizing some of the parameters such as learning parameter, and 
neuron number. Since microRNAs may play a role in human cancer pathogenesis, we have shown that, it is possible to predict 
relationships of microRNAs, p-values with different score values. Therefore, by using BPMLP, it is possible to predict 
microRNAs responsible from cancer pathogenesis at earlier stages. 
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1. Introduction 
     The early detection, diagnosis, and treatment of cancer are necessary before chemo-and/or radio-therapies and 
surgical operations. Circulating microRNAs as markers for cancer detection and monitoring could improve early 
diagnosis and reduce treatment costs and also mortality rate of the cancer [2]. MicroRNAs are small, non-coding, 
approximately 18-24 nts. A total of 10883 microRNAs have been identified and 721 microRNAs belong to Homo 
sapiens [3]. Our understanding of microRNAs has grown significantly in the last eight years. Many independent 
studies on different tissues demonstrated that cancer cells have different microRNA profiles compared with normal 
cells (Table I). Recent works have shown that microRNA mutations correlate with various human cancers and 
indicate that microRNAs can function as tumor suppressors and oncogenes [4-7]. 
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Table I.Examples of  MicroRNAs involved in different  types of cancers. 
Name of microRNA Type of cancer References 
miR-21,125b, 145, 155 Breast 4 
miR-10b Metastatic breast 
cancer 
5 
miR-20a 
miR-106b 
miR-32 
miR-221/222 
miR-15, 16 
 
 
Prostate cancer 
Prostate cancer 
Prostate cancer  
Prostate cancer 
Chronic 
lymphocytic 
leukemia  
6 
6 
6 
6 
7 
 
Owing to the power of microRNAs in regulating several genes in post-transcriptional level they may be used in anti-
cancer therapy and their profiles could be used for diagnosis. Today, technical developments allow us to measure 
the accumulation level of all known microRNAs using different approaches. The microarray, bead-based flow 
cytometry and quantitative PCR are some of these techniques. ONCOMINE is a cancer microarray database and 
web-based data-mining platform aimed at facilitating discovery from genome-wide expression analyses [8].  This 
study developed a neural network with back-propagation learning algorithm for the prediction of microRNAs 
responsible from cancer pathogenesis at earlier stages by using cancer microarray data from public ONCOMINE 
database. The aim of this research was to develop a nonlinear empirical model and to predict a score value for 
specific microRNAs responsible from cancer pathogenesis. 
2.0. Methods  
In this work, the Back-Propagation Multi Layer perceptron (BPMLP) for the prediction of score value is used. 
The architecture is the most commonly used multi-input single-output (MISO) system [9]. It consists of one input 
layer with M inputs, one output layer with one output and one hidden layers with varying number of nodes. The 
BPMLP neural network is a type of supervised, error correction learning that calculates an error on the output layer 
and propagates that error backwards through the network to determine how each individual weight factor contributes 
to the output error. The steepest-descent gradient approach used by the BPMLP to minimize the mean square error 
function and the local error function [9] defined as: 
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where, djp is the desired output signal of the jth output neuron for the pth example, n is the length of each example 
and yjp is the output signal. The total error function is defined as: 
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         In this study, the number of inputs M was 2. The data from the input neurons is then propagated through the 
network via the interconnections such that every neuron in a layer is connected to every neuron in the adjacent 
layers.  
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Where yj and  .M is the unipolar sigmoid activation function and uj is defined in equation 4 with its bias value jT . 
In addition to the weighted inputs to the neuron, a bias is included in order to shift the space of the nonlinearity. 
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In order to improve the back propagation multiplayer learning algorithm, the weight changes smoothed by 
overrelaxation. A momentum term defined as: 
   1' ' kwykw jijjji DKG                                                                                                                          (5) 
where, 10 ddD   
The second term in formula 5 is called the momentum term that makes the current (k-th) search directions. 
Momentum term enables the improvement of the convergence rate and the steady state performance of the back-
propagation multi layer learning algorithm. In this work, the number of input neurons is fixed at two, number of 
hidden neurons is 20 and the number of output neuron is one. The 677 micro-array data were collected from a 
cancer microarray database and data-mining platform called Oncomine. Testing data are classified into randomly 
selected four groups of data. 
3.0  Results and Discussions 
        A BPMLP, is used to establish the relationship between the microRNAs, p-value and score value. Accuracy 
rate was adjusted to 80 % and 90 %. The best performance was obtained with 20 neurons in the hidden layer and 
learning parameter as 0.00099.  
The neural network was trained using randomly selected 50 data from the database in order to provide 
effective prediction of untrained data. Once the network converges (learns), this phase will only comprise 
generalizing the trained neural network using one forward pass.  
The neural network consists of an input layer with 2 neurons, one hidden layer with 20 neurons which 
assures meaningful training while keeping the time cost to a minimum. The choice of 20 neurons in the hidden layer 
was a result of various training experiments. The output layer has only one neuron which yields normalized values 
(0 to 1) representing the score values. The activation function used for the processing neurons in the hidden and 
output layers is the sigmoid function. Throughout the learning phase, the learning coefficient and the momentum 
rate were adjusted several times in various experiments in order to achieve the required minimum error value of 
0.002 which was considered as sufficient for this application after several experiments. The initial random weights 
for the first iteration were limited to a range of values between (−0.8 and 0.8).  Table II lists the final parameters of 
the trained neural network. 
Table II.Final parameters used in the training and testing stages 
Input 
Neurons 
Hidden  
Neurons           
 
Output 
Neurons 
Learning 
Rate 
Momentum 
Rate 
 
LMS 
Error 
Number of 
Iterations 
Training 
Time 
                                       
2 20 1 0.00099                 0.91                    0.002           1526 63 s 
        
 
The training and testing set accuracies were listed on Table III. The total percent accuracy with level of significance 
(α) 72.5 % and 75 % with α=0.2.  
Table III.Training and testing sets 
Sets Number of 
                          Data 
Accuracy 
(α=0.2) 
Accuracy 
(α=0.1) 
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Training set        50 
Testing set1        100 
Testing set2        100 
100 % 
82 % 
85 % 
100 % 
73 % 
85 % 
 
Testing set3        100 77 % 70 %  
Testing set4        100 
Total 
 79 % 
 75 % 
70 % 
72.5 % 
 
 
MSE 
 
 
                                                Number of iterations 
 
Figure I Mean square error (MSE) versus number of iterations 
4. 0 Conclusion and Recommendations 
BPMLP is obtained by developing forward propagation phase and sensitivity network. It is shown that, the 
generalization capability can be significantly improved by optimizing some of the parameters such as learning rate, 
momentum rate and neuron number. Since microRNAs may play a role in human cancer pathogenesis, we have 
shown that, it is possible to predict relationships of microRNAs, p-values with different score values. Therefore, by 
using BPMLP, it is possible to predict microRNAs responsible from cancer pathogenesis at earlier stages. 
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